0,0,'DDI-DrugBank.d500.s0|DDI-DrugBank.d500.s0.e0|DDI-DrugBank.d500.s0.e1','Because ','tetracyclines',' have been shown to depress plasma prothrombin activity #  patients who are on DrugName therapy may require downward adjustment of thei','anticoagulant','me dosage.','null','null','null','[Because]','[me, dosage, null]','INBecause ','INbecause ','INbecaus ','NNStetracyclines VHPhave VBNbeen VVNshown TOto VVdepress NNplasma NNprothrombin NNactivity ,, NNSpatients WPwho VBPare INon JJanticoagulant NNtherapy MDmay VVrequire JJdownward NNadjustment INof PP$their ','NNStetracycline VHPhave VBNbe VVNshow TOto VVdepress NNplasma NNprothrombin NNactivity ,, NNSpatient WPwho VBPbe INon JJanticoagulant NNtherapy MDmay VVrequire JJdownward NNadjustment INof PP$their ','NNStetracyclin VHPhav VBNbeen VVNshown TOto VVdepress NNplasm NNprothrombin NNact ,, NNSpaty WPwho VBPare INon JJanticoag NNtherapy MDmay VVrequir JJdownward NNadjust INof PP$their ','JJanticoagulant NNdosage SENT. ','JJanticoagulant NNdosage SENT. ','JJanticoag NNdos SENT. ','becaus tetracyclin hav been shown to depress plasm prothrombin act , paty who are on anticoag therapy may requir downward adjust of their anticoag dos . ','tetracyclines	','Because	','anticoagulant	','therapy	may	require	','NNS	','IN	','JJ	','NN	MD	VV	','tetracycline	','because	','anticoagulant	','therapy	may	require	','have	been	shown	depress	are	','','','VHP	VBN	VVN	VV	VBP	','','','have	be	show	depress	be	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP DrugNameF)), (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity))))))))), (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))) (,^S ,) (NP^S-R-v (NP^NP-B (NNS^NP patients)) (SBAR^NP-v (WHNP^SBAR (WP^WHNP who)) (S^SBAR-U-v-G (VP^S-VBF-v (VBP^VP-BE are) (PP^VP (IN^PP on) (NP^PP-B (NNP^NP DrugNameS) (NN^NP therapy))))))) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))) (.^S .)), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))), (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))))), (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))), (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))), (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)), (NNP^NP DrugNameS), DrugNameS]','[Because, (IN^SBAR-SCC Because), (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))), (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity))))))))), (NP^S-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)), (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))), (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))), (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))))), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))) (,^S ,) (NP^S-R-v (NP^NP-B (NNS^NP patients)) (SBAR^NP-v (WHNP^SBAR (WP^WHNP who)) (S^SBAR-U-v-G (VP^S-VBF-v (VBP^VP-BE are) (PP^VP (IN^PP on) (NP^PP-B (NNP^NP DrugNameS) (NN^NP therapy))))))) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vSBAR^S-vIN^SBAR-SCCBecauseS^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity,^S,NP^S-R-vNP^NP-BNNS^NPpatientsSBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapyVP^S-VBF-vMD^VPmayVP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage.^S. S^ROOT-vSBAR^S-vIN^SBAR-SCCBecauseS^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity,^S,NP^S-R-vNP^NP-BNNS^NPpatientsSBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapyVP^S-VBF-vMD^VPmayVP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage.^S. SBAR^S-vIN^SBAR-SCCBecauseS^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity IN^SBAR-SCCBecause Because S^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity NP^S-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VBP^VP-HVhave have VP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VBN^VP-BEbeen been VP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VBN^VPshown shown S^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity TO^VPto to VP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VB^VPdepress depress NP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity NN^NPplasma plasma NN^NPprothrombin prothrombin NN^NPactivity activity ,^S, , NP^S-R-vNP^NP-BNNS^NPpatientsSBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy NP^NP-BNNS^NPpatients NNS^NPpatients patients SBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy WHNP^SBARWP^WHNPwho WP^WHNPwho who S^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy VP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy VBP^VP-BEare are PP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy IN^PPon on NP^PP-BNNP^NPDrugNameSNN^NPtherapy NNP^NPDrugNameS DrugNameS NN^NPtherapy therapy VP^S-VBF-vMD^VPmayVP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage MD^VPmay may VP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage VB^VPrequire require NP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage NP^NP-BJJ^NPdownwardNN^NPadjustment JJ^NPdownward downward NN^NPadjustment adjustment PP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage IN^PP-Nof of NP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage PRP$^NPtheir their NNP^NPDrugNameS DrugNameS NN^NPdosage dosage .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s0|DDI-DrugBank.d500.s0.e0|DDI-DrugBank.d500.s0.e2','Because ','tetracyclines',' have been shown to depress plasma prothrombin activity #  patients who are on DrugName therapy may require downward adjustment of thei','anticoagulant','me dosage.','null','null','null','[Because]','[me, dosage, null]','INBecause ','INbecause ','INbecaus ','NNStetracyclines VHPhave VBNbeen VVNshown TOto VVdepress NNplasma NNprothrombin NNactivity ,, NNSpatients WPwho VBPare INon JJanticoagulant NNtherapy MDmay VVrequire JJdownward NNadjustment INof PP$their ','NNStetracycline VHPhave VBNbe VVNshow TOto VVdepress NNplasma NNprothrombin NNactivity ,, NNSpatient WPwho VBPbe INon JJanticoagulant NNtherapy MDmay VVrequire JJdownward NNadjustment INof PP$their ','NNStetracyclin VHPhav VBNbeen VVNshown TOto VVdepress NNplasm NNprothrombin NNact ,, NNSpaty WPwho VBPare INon JJanticoag NNtherapy MDmay VVrequir JJdownward NNadjust INof PP$their ','JJanticoagulant NNdosage SENT. ','JJanticoagulant NNdosage SENT. ','JJanticoag NNdos SENT. ','becaus tetracyclin hav been shown to depress plasm prothrombin act , paty who are on anticoag therapy may requir downward adjust of their anticoag dos . ','tetracyclines	','Because	','anticoagulant	','therapy	may	require	','NNS	','IN	','JJ	','NN	MD	VV	','tetracycline	','because	','anticoagulant	','therapy	may	require	','have	been	shown	depress	are	','','','VHP	VBN	VVN	VV	VBP	','','','have	be	show	depress	be	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP DrugNameF)), (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity))))))))), (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))) (,^S ,) (NP^S-R-v (NP^NP-B (NNS^NP patients)) (SBAR^NP-v (WHNP^SBAR (WP^WHNP who)) (S^SBAR-U-v-G (VP^S-VBF-v (VBP^VP-BE are) (PP^VP (IN^PP on) (NP^PP-B (NNP^NP DrugNameS) (NN^NP therapy))))))) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))) (.^S .)), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))), (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))))), (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))), (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))), (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)), (NNP^NP DrugNameS), DrugNameS]','[Because, (IN^SBAR-SCC Because), (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))), (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity))))))))), (NP^S-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)), (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))), (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))), (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage))))), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Because) (S^SBAR-v (NP^S-B (NNP^NP DrugNameF)) (VP^S-VBF-v (VBP^VP-HV have) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP shown) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP depress) (NP^VP-B (NN^NP plasma) (NN^NP prothrombin) (NN^NP activity)))))))))) (,^S ,) (NP^S-R-v (NP^NP-B (NNS^NP patients)) (SBAR^NP-v (WHNP^SBAR (WP^WHNP who)) (S^SBAR-U-v-G (VP^S-VBF-v (VBP^VP-BE are) (PP^VP (IN^PP on) (NP^PP-B (NNP^NP DrugNameS) (NN^NP therapy))))))) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP require) (NP^VP-R (NP^NP-B (JJ^NP downward) (NN^NP adjustment)) (PP^NP (IN^PP-N of) (NP^PP-B (PRP$^NP their) (NNP^NP DrugNameS) (NN^NP dosage)))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vSBAR^S-vIN^SBAR-SCCBecauseS^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity,^S,NP^S-R-vNP^NP-BNNS^NPpatientsSBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapyVP^S-VBF-vMD^VPmayVP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage.^S. S^ROOT-vSBAR^S-vIN^SBAR-SCCBecauseS^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity,^S,NP^S-R-vNP^NP-BNNS^NPpatientsSBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapyVP^S-VBF-vMD^VPmayVP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage.^S. SBAR^S-vIN^SBAR-SCCBecauseS^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity IN^SBAR-SCCBecause Because S^SBAR-vNP^S-BNNP^NPDrugNameFVP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity NP^S-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBP^VP-HVhaveVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VBP^VP-HVhave have VP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VBN^VP-BEbeen been VP-VBN-vVBN^VPshownS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VBN^VPshown shown S^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VP^S-TO-vTO^VPtoVP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity TO^VPto to VP-VB-vVB^VPdepressNP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity VB^VPdepress depress NP^VP-BNN^NPplasmaNN^NPprothrombinNN^NPactivity NN^NPplasma plasma NN^NPprothrombin prothrombin NN^NPactivity activity ,^S, , NP^S-R-vNP^NP-BNNS^NPpatientsSBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy NP^NP-BNNS^NPpatients NNS^NPpatients patients SBAR^NP-vWHNP^SBARWP^WHNPwhoS^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy WHNP^SBARWP^WHNPwho WP^WHNPwho who S^SBAR-U-v-GVP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy VP^S-VBF-vVBP^VP-BEarePP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy VBP^VP-BEare are PP^VPIN^PPonNP^PP-BNNP^NPDrugNameSNN^NPtherapy IN^PPon on NP^PP-BNNP^NPDrugNameSNN^NPtherapy NNP^NPDrugNameS DrugNameS NN^NPtherapy therapy VP^S-VBF-vMD^VPmayVP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage MD^VPmay may VP-VB-vVB^VPrequireNP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage VB^VPrequire require NP^VP-RNP^NP-BJJ^NPdownwardNN^NPadjustmentPP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage NP^NP-BJJ^NPdownwardNN^NPadjustment JJ^NPdownward downward NN^NPadjustment adjustment PP^NPIN^PP-NofNP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage IN^PP-Nof of NP^PP-BPRP$^NPtheirNNP^NPDrugNameSNN^NPdosage PRP$^NPtheir their NNP^NPDrugNameS DrugNameS NN^NPdosage dosage .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s0|DDI-DrugBank.d500.s0.e1|DDI-DrugBank.d500.s0.e2','Because tetracyclines have been shown to depress plasma prothrombin activity #  patients who are o','anticoagulant','me therapy may require downward adjustment of thei','anticoagulant','me dosage.','null','null','null','[who, are, o]','[me, dosage, null]','INBecause NNStetracyclines VHPhave VBNbeen VVNshown TOto VVdepress NNplasma NNprothrombin NNactivity ,, NNSpatients WPwho VBPare INon JJanticoagulant NNtherapy MDmay VVrequire JJdownward NNadjustment INof PP$their ','INbecause NNStetracycline VHPhave VBNbe VVNshow TOto VVdepress NNplasma NNprothrombin NNactivity ,, NNSpatient WPwho VBPbe INon JJanticoagulant NNtherapy MDmay VVrequire JJdownward NNadjustment INof PP$their ','INbecaus NNStetracyclin VHPhav VBNbeen VVNshown TOto VVdepress NNplasm NNprothrombin NNact ,, NNSpaty WPwho VBPare INon JJanticoag NNtherapy MDmay VVrequir JJdownward NNadjust INof PP$their ','JJanticoagulant NNdosage ','JJanticoagulant NNdosage ','JJanticoag NNdos ','SENT. ','SENT. ','SENT. ','becaus tetracyclin hav been shown to depress plasm prothrombin act , paty who are on anticoag therapy may requir downward adjust of their anticoag dos . ','anticoagulant	','on	are	who	','anticoagulant	','dosage	.	','JJ	','IN	VBP	WP	','JJ	','NN	SENT	','anticoagulant	','on	be	who	','anticoagulant	','dosage	.	','require	','are	','','VV	','VBP	','','require	','be	','','','','','','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s1|DDI-DrugBank.d500.s1.e0|DDI-DrugBank.d500.s1.e1','Since bacteriostatic drugs may interfere with the bactericidal action of ','penicillin',' #  it is advisable to avoid giving DrugName in conjunction wit','tetracyclines','me.','null','null','null','[bactericidal, action, of]','[me, null]','INSince JJbacteriostatic NNSdrugs MDmay VVinterfere INwith DTthe JJbactericidal NNaction INof NNpenicillin ,, PPit VBZis JJadvisable TOto VVavoid VVGgiving NNStetracyclines INin NNconjunction INwith ','INsince JJbacteriostatic NNSdrug MDmay VVinterfere INwith DTthe JJbactericidal NNaction INof NNpenicillin ,, PPit VBZbe JJadvisable TOto VVavoid VVGgive NNStetracycline INin NNconjunction INwith ','INsint JJbacteriost NNSdrug MDmay VVinterf INwith DTthe JJbactericid NNact INof NNpenicillin ,, PPit VBZis JJadv TOto VVavoid VVGgiv NNStetracyclin INin NNconjunct INwith ','','','','NNStetracyclines INin NNconjunction INwith NNpenicillin SENT. ','NNStetracycline INin NNconjunction INwith NNpenicillin SENT. ','NNStetracyclin INin NNconjunct INwith NNpenicillin SENT. ','sint bacteriost drug may interf with the bactericid act of penicillin , it is adv to avoid giv tetracyclin in conjunct with penicillin . ','penicillin	','of	action	bactericidal	','tetracyclines	','in	conjunction	with	','NN	','IN	NN	JJ	','NNS	','IN	NN	IN	','penicillin	','of	action	bactericidal	','tetracycline	','in	conjunction	with	','is	avoid	giving	','interfere	','','VBZ	VV	VVG	','VV	','','be	avoid	give	','interfere	','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))), (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))))), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))))), (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))))))), (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))))))) (,^S ,) (NP^S-B (PRP^NP it)) (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))))))), (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF))))))))), (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))))), (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF))))))), (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF))))), (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))), (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))), (NP^NP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Since, (IN^SBAR-SCC Since), (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))))))), (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))))))), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))))), (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))))), (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))), (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^NP-B (NNP^NP DrugNameS)), (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))), (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF))))), (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))), (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF))))))), (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))))), (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF))))))))), (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))))))))) (,^S ,) (NP^S-B (PRP^NP it)) (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameS)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameF)))))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vSBAR^S-vIN^SBAR-SCCSinceS^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF,^S,NP^S-BPRP^NPitVP^S-VBF-vVBZ^VP-BEisADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF.^S. S^ROOT-vSBAR^S-vIN^SBAR-SCCSinceS^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF,^S,NP^S-BPRP^NPitVP^S-VBF-vVBZ^VP-BEisADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF.^S. SBAR^S-vIN^SBAR-SCCSinceS^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^SBAR-SCCSince Since S^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^S-BJJ^NPbacteriostaticNNS^NPdrugs JJ^NPbacteriostatic bacteriostatic NNS^NPdrugs drugs VP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF MD^VPmay may VP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF VB^VPinterfere interfere PP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PPwith with NP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BDT^NPtheJJ^NPbactericidalNN^NPaction DT^NPthe the JJ^NPbactericidal bactericidal NN^NPaction action PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF ,^S, , NP^S-BPRP^NPit PRP^NPit it VP^S-VBF-vVBZ^VP-BEisADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF VBZ^VP-BEis is ADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF JJ^ADJPadvisable advisable S^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF VP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF TO^VPto to VP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF VB^VPavoid avoid S^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF VP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF VBG^VPgiving giving NP^VP-RNP^NP-BNNP^NPDrugNameSPP^NPIN^PP-NinNP^PP-BNN^NPconjunction NP^NP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS PP^NPIN^PP-NinNP^PP-BNN^NPconjunction IN^PP-Nin in NP^PP-BNN^NPconjunction NN^NPconjunction conjunction PP^VPIN^PPwithNP^PP-BNNP^NPDrugNameF IN^PPwith with NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s1|DDI-DrugBank.d500.s1.e0|DDI-DrugBank.d500.s1.e2','Since bacteriostatic drugs may interfere with the bactericidal action of ','penicillin',' #  it is advisable to avoid giving tetracyclines in conjunction wit','penicillin','me.','null','null','null','[bactericidal, action, of]','[me, null]','INSince JJbacteriostatic NNSdrugs MDmay VVinterfere INwith DTthe JJbactericidal NNaction INof NNpenicillin ,, PPit VBZis JJadvisable TOto VVavoid VVGgiving NNStetracyclines INin NNconjunction INwith ','INsince JJbacteriostatic NNSdrug MDmay VVinterfere INwith DTthe JJbactericidal NNaction INof NNpenicillin ,, PPit VBZbe JJadvisable TOto VVavoid VVGgive NNStetracycline INin NNconjunction INwith ','INsint JJbacteriost NNSdrug MDmay VVinterf INwith DTthe JJbactericid NNact INof NNpenicillin ,, PPit VBZis JJadv TOto VVavoid VVGgiv NNStetracyclin INin NNconjunct INwith ','NNpenicillin ','NNpenicillin ','NNpenicillin ','SENT. ','SENT. ','SENT. ','sint bacteriost drug may interf with the bactericid act of penicillin , it is adv to avoid giv tetracyclin in conjunct with penicillin . ','penicillin	','of	action	bactericidal	','penicillin	','.	','NN	','IN	NN	JJ	','NN	','SENT	','penicillin	','of	action	bactericidal	','penicillin	','.	','is	avoid	giving	','interfere	','','VBZ	VV	VVG	','VV	','','be	avoid	give	','interfere	','','','','','','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s1|DDI-DrugBank.d500.s1.e1|DDI-DrugBank.d500.s1.e2','Since bacteriostatic drugs may interfere with the bactericidal action of ','tetracyclines',' #  it is advisable to avoid giving DrugName in conjunction wit','penicillin','me.','null','null','null','[bactericidal, action, of]','[me, null]','INSince JJbacteriostatic NNSdrugs MDmay VVinterfere INwith DTthe JJbactericidal NNaction INof NNpenicillin ,, PPit VBZis JJadvisable TOto VVavoid VVGgiving ','INsince JJbacteriostatic NNSdrug MDmay VVinterfere INwith DTthe JJbactericidal NNaction INof NNpenicillin ,, PPit VBZbe JJadvisable TOto VVavoid VVGgive ','INsint JJbacteriost NNSdrug MDmay VVinterf INwith DTthe JJbactericid NNact INof NNpenicillin ,, PPit VBZis JJadv TOto VVavoid VVGgiv ','NNStetracyclines INin NNconjunction INwith ','NNStetracycline INin NNconjunction INwith ','NNStetracyclin INin NNconjunct INwith ','NNpenicillin SENT. ','NNpenicillin SENT. ','NNpenicillin SENT. ','sint bacteriost drug may interf with the bactericid act of penicillin , it is adv to avoid giv tetracyclin in conjunct with penicillin . ','tetracyclines	','giving	avoid	to	','penicillin	','.	','NNS	','VVG	VV	TO	','NN	','SENT	','tetracycline	','give	avoid	to	','penicillin	','.	','','giving	','','','VVG	','','','give	','','[DrugNameF, (NNP^NP DrugNameF), (NP^NP-B (NNP^NP DrugNameF)), (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))), (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))), (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Since, (IN^SBAR-SCC Since), (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))))))) (,^S ,) (NP^S-B (PRP^NP it)) (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))))))), (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))))))))), (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))))), (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))))))), (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))))), (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))), (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))), (NP^NP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameS)), (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))), (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))))), (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))), (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))))))), (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))))), (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS))))))))), (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))))))), (S^ROOT-v (SBAR^S-v (IN^SBAR-SCC Since) (S^SBAR-v (NP^S-B (JJ^NP bacteriostatic) (NNS^NP drugs)) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP interfere) (PP^VP (IN^PP with) (NP^PP-R (NP^NP-B (DT^NP the) (JJ^NP bactericidal) (NN^NP action)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))))))) (,^S ,) (NP^S-B (PRP^NP it)) (VP^S-VBF-v (VBZ^VP-BE is) (ADJP^VP-v (JJ^ADJP advisable) (S^ADJP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP avoid) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP giving) (NP^VP-R (NP^NP-B (NNP^NP DrugNameF)) (PP^NP (IN^PP-N in) (NP^PP-B (NN^NP conjunction)))) (PP^VP (IN^PP with) (NP^PP-B (NNP^NP DrugNameS)))))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vSBAR^S-vIN^SBAR-SCCSinceS^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS,^S,NP^S-BPRP^NPitVP^S-VBF-vVBZ^VP-BEisADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS.^S. S^ROOT-vSBAR^S-vIN^SBAR-SCCSinceS^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS,^S,NP^S-BPRP^NPitVP^S-VBF-vVBZ^VP-BEisADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS.^S. SBAR^S-vIN^SBAR-SCCSinceS^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS IN^SBAR-SCCSince Since S^SBAR-vNP^S-BJJ^NPbacteriostaticNNS^NPdrugsVP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS NP^S-BJJ^NPbacteriostaticNNS^NPdrugs JJ^NPbacteriostatic bacteriostatic NNS^NPdrugs drugs VP^S-VBF-vMD^VPmayVP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS MD^VPmay may VP-VB-vVB^VPinterferePP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS VB^VPinterfere interfere PP^VPIN^PPwithNP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS IN^PPwith with NP^PP-RNP^NP-BDT^NPtheJJ^NPbactericidalNN^NPactionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS NP^NP-BDT^NPtheJJ^NPbactericidalNN^NPaction DT^NPthe the JJ^NPbactericidal bactericidal NN^NPaction action PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS IN^PP-Nof of NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS ,^S, , NP^S-BPRP^NPit PRP^NPit it VP^S-VBF-vVBZ^VP-BEisADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS VBZ^VP-BEis is ADJP^VP-vJJ^ADJPadvisableS^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS JJ^ADJPadvisable advisable S^ADJP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS VP^S-TO-vTO^VPtoVP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS TO^VPto to VP-VB-vVB^VPavoidS^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS VB^VPavoid avoid S^VP-U-v-GVP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS VP^S-VBG-vVBG^VPgivingNP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunctionPP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS VBG^VPgiving giving NP^VP-RNP^NP-BNNP^NPDrugNameFPP^NPIN^PP-NinNP^PP-BNN^NPconjunction NP^NP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF PP^NPIN^PP-NinNP^PP-BNN^NPconjunction IN^PP-Nin in NP^PP-BNN^NPconjunction NN^NPconjunction conjunction PP^VPIN^PPwithNP^PP-BNNP^NPDrugNameS IN^PPwith with NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e0|DDI-DrugBank.d500.s2.e1','Absorption of ','tetracyclines',' is impaired by ','antacids',' containing aluminum #  calcium #  or magnesium #  and iron-containing preparations.','null','null','null','[Absorption, of]','[, containing, aluminum, #]','NNAbsorption INof ','NNabsorption INof ','NNabsorb INof ','NNStetracyclines VBZis VVNimpaired INby ','NNStetracycline VBZbe VVNimpair INby ','NNStetracyclin VBZis VVNimpair INby ','NNSantacids VVGcontaining NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNSantacid VVGcontain NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNSantacid VVGcontain NNalumin ,, NNcalc ,, CCor NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','tetracyclines	','of	Absorption	','antacids	','containing	aluminum	,	','NNS	','IN	NN	','NNS	','VVG	NN	,	','tetracycline	','of	absorption	','antacid	','contain	aluminum	,	','is	impaired	','','containing	','VBZ	VVN	','','VVG	','be	impair	','','contain	','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameS)), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameSS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameSS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameSS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameSS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VPIN^PPbyNP^PP-BNNP^NPDrugNameS IN^PPby by NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS S^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP, NN^NPaluminum aluminum ,^NP, , NN^NPcalcium calcium ,^NP, , CC^NP-Cor or NN^NPmagnesium magnesium ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e0|DDI-DrugBank.d500.s2.e2','Absorption of ','tetracyclines',' is impaired by antacids containing ','aluminum',' #  calcium #  or magnesium #  and iron-containing preparations.','null','null','null','[Absorption, of]','[, #, calcium, #]','NNAbsorption INof ','NNabsorption INof ','NNabsorb INof ','NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining ','NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain ','NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain ','NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNalumin ,, NNcalc ,, CCor NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','tetracyclines	','of	Absorption	','aluminum	',',	calcium	,	','NNS	','IN	NN	','NN	',',	NN	,	','tetracycline	','of	absorption	','aluminum	',',	calcium	,	','is	impaired	containing	','','','VBZ	VVN	VVG	','','','be	impair	contain	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations IN^PPby by NP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNNS^NPantacids NNS^NPantacids antacids VP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP, NN^NPDrugNameS DrugNameS ,^NP, , NN^NPcalcium calcium ,^NP, , CC^NP-Cor or NN^NPmagnesium magnesium ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e0|DDI-DrugBank.d500.s2.e3','Absorption of ','tetracyclines',' is impaired by antacids containing aluminum #','calcium','me #  or magnesium #  and iron-containing preparations.','null','null','null','[Absorption, of]','[me, #, or, magnesium]','NNAbsorption INof ','NNabsorption INof ','NNabsorb INof ','NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining NNaluminum ,, ','NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain NNaluminum ,, ','NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain NNalumin ,, ','NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNcalc ,, CCor NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','tetracyclines	','of	Absorption	','calcium	',',	or	magnesium	','NNS	','IN	NN	','NN	',',	CC	NN	','tetracycline	','of	absorption	','calcium	',',	or	magnesium	','is	impaired	containing	','','','VBZ	VVN	VVG	','','','be	impair	contain	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations IN^PPby by NP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNNS^NPantacids NNS^NPantacids antacids VP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP, NN^NPaluminum aluminum ,^NP, , NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cor or NN^NPmagnesium magnesium ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e0|DDI-DrugBank.d500.s2.e4','Absorption of ','tetracyclines',' is impaired by antacids containing aluminum #  calcium # ','magnesium','Name #  and iron-containing preparations.','null','null','null','[Absorption, of]','[Name, #, and, iron-containing]','NNAbsorption INof ','NNabsorption INof ','NNabsorb INof ','NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining NNaluminum ,, NNcalcium ,, CCor ','NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain NNaluminum ,, NNcalcium ,, CCor ','NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain NNalumin ,, NNcalc ,, CCor ','NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','tetracyclines	','of	Absorption	','magnesium	',',	and	iron-containing	','NNS	','IN	NN	','NN	',',	CC	NN	','tetracycline	','of	absorption	','magnesium	',',	and	iron-containing	','is	impaired	containing	','','','VBZ	VVN	VVG	','','','be	impair	contain	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations IN^PPby by NP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNNS^NPantacids NNS^NPantacids antacids VP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP, NN^NPaluminum aluminum ,^NP, , NN^NPcalcium calcium ,^NP, , CC^NP-Cor or NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e0|DDI-DrugBank.d500.s2.e5','Absorption of ','tetracyclines',' is impaired by antacids containing aluminum #  calcium #  or magnesium #','iron','ugName-containing preparations.','null','null','null','[Absorption, of]','[ugName-containing, preparations, null]','NNAbsorption INof ','NNabsorption INof ','NNabsorb INof ','NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparations ','NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparation ','NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain NNalumin ,, NNcalc ,, CCor NNmagnes ,, CCand NPdrugnamescontain NNSprep ','SENT. ','SENT. ','SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and drugnamescontain prep . ','tetracyclines	','of	Absorption	','','','NNS	','IN	NN	','','','tetracycline	','of	absorption	','','','is	impaired	containing	','','is	','VBZ	VVN	VVG	','','VBZ	','be	impair	contain	','','be	','','','','','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e1|DDI-DrugBank.d500.s2.e2','Absorption of tetracyclines is impaired by ','antacids',' containing ','aluminum',' #  calcium #  or magnesium #  and iron-containing preparations.','null','null','null','[is, impaired, by]','[, #, calcium, #]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby ','NNSantacids VVGcontaining ','NNSantacid VVGcontain ','NNSantacid VVGcontain ','NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNalumin ,, NNcalc ,, CCor NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','antacids	','by	impaired	is	','aluminum	',',	calcium	,	','NNS	','IN	VVN	VBZ	','NN	',',	NN	,	','antacid	','by	impair	be	','aluminum	',',	calcium	,	','containing	','impaired	','','VVG	','VVN	','','contain	','impair	','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameS) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines IN^PP-Nof of NP^PP-BNNS^NPtetracyclines NNS^NPtetracyclines tetracyclines VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VPIN^PPbyNP^PP-BNNP^NPDrugNameF IN^PPby by NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF S^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPDrugNameS,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPmagnesium,^NP, NN^NPDrugNameS DrugNameS ,^NP, , NN^NPcalcium calcium ,^NP, , CC^NP-Cor or NN^NPmagnesium magnesium ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e1|DDI-DrugBank.d500.s2.e3','Absorption of tetracyclines is impaired by ','antacids',' containing aluminum #','calcium','me #  or magnesium #  and iron-containing preparations.','null','null','null','[is, impaired, by]','[me, #, or, magnesium]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby ','NNSantacids VVGcontaining NNaluminum ,, ','NNSantacid VVGcontain NNaluminum ,, ','NNSantacid VVGcontain NNalumin ,, ','NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNcalc ,, CCor NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','antacids	','by	impaired	is	','calcium	',',	or	magnesium	','NNS	','IN	VVN	VBZ	','NN	',',	CC	NN	','antacid	','by	impair	be	','calcium	',',	or	magnesium	','containing	','impaired	','','VVG	','VVN	','','contain	','impair	','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines IN^PP-Nof of NP^PP-BNNS^NPtetracyclines NNS^NPtetracyclines tetracyclines VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VPIN^PPbyNP^PP-BNNP^NPDrugNameF IN^PPby by NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF S^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP, NN^NPaluminum aluminum ,^NP, , NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cor or NN^NPmagnesium magnesium ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e1|DDI-DrugBank.d500.s2.e4','Absorption of tetracyclines is impaired by ','antacids',' containing aluminum #  calcium # ','magnesium','Name #  and iron-containing preparations.','null','null','null','[is, impaired, by]','[Name, #, and, iron-containing]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby ','NNSantacids VVGcontaining NNaluminum ,, NNcalcium ,, CCor ','NNSantacid VVGcontain NNaluminum ,, NNcalcium ,, CCor ','NNSantacid VVGcontain NNalumin ,, NNcalc ,, CCor ','NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','antacids	','by	impaired	is	','magnesium	',',	and	iron-containing	','NNS	','IN	VVN	VBZ	','NN	',',	CC	NN	','antacid	','by	impair	be	','magnesium	',',	and	iron-containing	','containing	','impaired	','','VVG	','VVN	','','contain	','impair	','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameF))) (S^VP-U-v-G (VP^S-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines IN^PP-Nof of NP^PP-BNNS^NPtetracyclines NNS^NPtetracyclines tetracyclines VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameFS^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VPIN^PPbyNP^PP-BNNP^NPDrugNameF IN^PPby by NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF S^VP-U-v-GVP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VP^S-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPaluminum,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP, NN^NPaluminum aluminum ,^NP, , NN^NPcalcium calcium ,^NP, , CC^NP-Cor or NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e1|DDI-DrugBank.d500.s2.e5','Absorption of tetracyclines is impaired by ','antacids',' containing aluminum #  calcium #  or magnesium #','iron','ugName-containing preparations.','null','null','null','[is, impaired, by]','[ugName-containing, preparations, null]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby ','NNSantacids VVGcontaining NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparations ','NNSantacid VVGcontain NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparation ','NNSantacid VVGcontain NNalumin ,, NNcalc ,, CCor NNmagnes ,, CCand NPdrugnamescontain NNSprep ','SENT. ','SENT. ','SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and drugnamescontain prep . ','antacids	','by	impaired	is	','','','NNS	','IN	VVN	VBZ	','','','antacid	','by	impair	be	','','','containing	','impaired	','is	','VVG	','VVN	','VBZ	','contain	','impair	','be	','','','','','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e2|DDI-DrugBank.d500.s2.e3','Absorption of tetracyclines is impaired by antacids containing ','aluminum',' #','calcium','me #  or magnesium #  and iron-containing preparations.','null','null','null','[by, antacids, containing]','[me, #, or, magnesium]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain ','NNaluminum ,, ','NNaluminum ,, ','NNalumin ,, ','NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNcalcium ,, CCor NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNcalc ,, CCor NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','aluminum	','containing	antacids	by	','calcium	',',	or	magnesium	','NN	','VVG	NNS	IN	','NN	',',	CC	NN	','aluminum	','contain	antacid	by	','calcium	',',	or	magnesium	','','containing	','','','VVG	','','','contain	','','[DrugNameF, (NN^NP DrugNameF), (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NN^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP DrugNameS) (,^NP ,) (CC^NP-C or) (NN^NP magnesium) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines IN^PP-Nof of NP^PP-BNNS^NPtetracyclines NNS^NPtetracyclines tetracyclines VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations IN^PPby by NP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNNS^NPantacids NNS^NPantacids antacids VP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPDrugNameF,^NP,NN^NPDrugNameS,^NP,CC^NP-CorNN^NPmagnesium,^NP, NN^NPDrugNameF DrugNameF ,^NP, , NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cor or NN^NPmagnesium magnesium ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e2|DDI-DrugBank.d500.s2.e4','Absorption of tetracyclines is impaired by antacids containing ','aluminum',' #  calcium # ','magnesium','Name #  and iron-containing preparations.','null','null','null','[by, antacids, containing]','[Name, #, and, iron-containing]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain ','NNaluminum ,, NNcalcium ,, CCor ','NNaluminum ,, NNcalcium ,, CCor ','NNalumin ,, NNcalc ,, CCor ','NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','aluminum	','containing	antacids	by	','magnesium	',',	and	iron-containing	','NN	','VVG	NNS	IN	','NN	',',	CC	NN	','aluminum	','contain	antacid	by	','magnesium	',',	and	iron-containing	','','containing	','','','VVG	','','','contain	','','[DrugNameF, (NN^NP DrugNameF), (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NN^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP DrugNameF) (,^NP ,) (NN^NP calcium) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines IN^PP-Nof of NP^PP-BNNS^NPtetracyclines NNS^NPtetracyclines tetracyclines VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations IN^PPby by NP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNNS^NPantacids NNS^NPantacids antacids VP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPDrugNameF,^NP,NN^NPcalcium,^NP,CC^NP-CorNN^NPDrugNameS,^NP, NN^NPDrugNameF DrugNameF ,^NP, , NN^NPcalcium calcium ,^NP, , CC^NP-Cor or NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e2|DDI-DrugBank.d500.s2.e5','Absorption of tetracyclines is impaired by antacids containing ','aluminum',' #  calcium #  or magnesium #','iron','ugName-containing preparations.','null','null','null','[by, antacids, containing]','[ugName-containing, preparations, null]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain ','NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparations ','NNaluminum ,, NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparation ','NNalumin ,, NNcalc ,, CCor NNmagnes ,, CCand NPdrugnamescontain NNSprep ','SENT. ','SENT. ','SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and drugnamescontain prep . ','aluminum	','containing	antacids	by	','','','NN	','VVG	NNS	IN	','','','aluminum	','contain	antacid	by	','','','','containing	','is	','','VVG	','VBZ	','','contain	','be	','','','','','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e3|DDI-DrugBank.d500.s2.e4','Absorption of tetracyclines is impaired by antacids containing aluminum #','calcium','me # ','magnesium','Name #  and iron-containing preparations.','null','null','null','[containing, aluminum, #]','[Name, #, and, iron-containing]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining NNaluminum ,, ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain NNaluminum ,, ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain NNalumin ,, ','NNcalcium ,, CCor ','NNcalcium ,, CCor ','NNcalc ,, CCor ','NNmagnesium ,, CCand NNiron-containing NNSpreparations SENT. ','NNmagnesium ,, CCand NNiron-containing NNSpreparation SENT. ','NNmagnes ,, CCand NNironcontain NNSprep SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and ironcontain prep . ','calcium	',',	aluminum	containing	','magnesium	',',	and	iron-containing	','NN	',',	NN	VVG	','NN	',',	CC	NN	','calcium	',',	aluminum	contain	','magnesium	',',	and	iron-containing	','','containing	','','','VVG	','','','contain	','','[DrugNameF, (NN^NP DrugNameF), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NN^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NN^NP DrugNameF), DrugNameF]','[DrugNameS, (NN^NP DrugNameS), (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)), (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))), (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))), (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))), (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))), (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations))))))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNS^NP tetracyclines)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP-v (IN^PP by) (NP^PP-R-v (NP^NP-B (NNS^NP antacids)) (VP-VBG-v (VBG^VP containing) (NP^VP-R (NP^NP-B (NN^NP aluminum) (,^NP ,) (NN^NP DrugNameF) (,^NP ,) (CC^NP-C or) (NN^NP DrugNameS) (,^NP ,)) (CC^NP-C and) (NP^NP-B (JJ^NP iron-containing) (NNS^NP preparations)))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclinesVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNS^NPtetracyclines IN^PP-Nof of NP^PP-BNNS^NPtetracyclines NNS^NPtetracyclines tetracyclines VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBN^VPimpaired impaired PP^VP-vIN^PPbyNP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations IN^PPby by NP^PP-R-vNP^NP-BNNS^NPantacidsVP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNNS^NPantacids NNS^NPantacids antacids VP-VBG-vVBG^VPcontainingNP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations VBG^VPcontaining containing NP^VP-RNP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP,CC^NP-CandNP^NP-BJJ^NPiron-containingNNS^NPpreparations NP^NP-BNN^NPaluminum,^NP,NN^NPDrugNameF,^NP,CC^NP-CorNN^NPDrugNameS,^NP, NN^NPaluminum aluminum ,^NP, , NN^NPDrugNameF DrugNameF ,^NP, , CC^NP-Cor or NN^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cand and NP^NP-BJJ^NPiron-containingNNS^NPpreparations JJ^NPiron-containing iron-containing NNS^NPpreparations preparations .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e3|DDI-DrugBank.d500.s2.e5','Absorption of tetracyclines is impaired by antacids containing aluminum #','calcium','me #  or magnesium #','iron','ugName-containing preparations.','null','null','null','[containing, aluminum, #]','[ugName-containing, preparations, null]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining NNaluminum ,, ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain NNaluminum ,, ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain NNalumin ,, ','NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparations ','NNcalcium ,, CCor NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparation ','NNcalc ,, CCor NNmagnes ,, CCand NPdrugnamescontain NNSprep ','SENT. ','SENT. ','SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and drugnamescontain prep . ','calcium	',',	aluminum	containing	','','','NN	',',	NN	VVG	','','','calcium	',',	aluminum	contain	','','','','containing	','is	','','VVG	','VBZ	','','contain	','be	','','','','','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s2|DDI-DrugBank.d500.s2.e4|DDI-DrugBank.d500.s2.e5','Absorption of tetracyclines is impaired by antacids containing aluminum #  calcium # ','magnesium','Name #','iron','ugName-containing preparations.','null','null','null','[#, calcium, #]','[ugName-containing, preparations, null]','NNAbsorption INof NNStetracyclines VBZis VVNimpaired INby NNSantacids VVGcontaining NNaluminum ,, NNcalcium ,, CCor ','NNabsorption INof NNStetracycline VBZbe VVNimpair INby NNSantacid VVGcontain NNaluminum ,, NNcalcium ,, CCor ','NNabsorb INof NNStetracyclin VBZis VVNimpair INby NNSantacid VVGcontain NNalumin ,, NNcalc ,, CCor ','NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparations ','NNmagnesium ,, CCand NPDrugNameS-containing NNSpreparation ','NNmagnes ,, CCand NPdrugnamescontain NNSprep ','SENT. ','SENT. ','SENT. ','absorb of tetracyclin is impair by antacid contain alumin , calc , or magnes , and drugnamescontain prep . ','magnesium	','or	,	calcium	','','','NN	','CC	,	NN	','','','magnesium	','or	,	calcium	','','','','containing	','is	','','VVG	','VBZ	','','contain	','be	','','','','','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s3|DDI-DrugBank.d500.s3.e0|DDI-DrugBank.d500.s3.e1','Absorption of ','tetracycline',' is impaired by ','bismuth subsalicylate','.','null','null','null','[Absorption, of]','[]','NNAbsorption INof ','NNabsorption INof ','NNabsorb INof ','NNtetracycline VBZis VVNimpaired INby ','NNtetracycline VBZbe VVNimpair INby ','NNtetracyclin VBZis VVNimpair INby ','NNbismuth subsalicylate SENT. ','NNbismuth_subsalicylate SENT. ','NNbismuthsubsalicyl SENT. ','absorb of tetracyclin is impair by bismuthsubsalicyl . ','tetracycline	','of	Absorption	','bismuth subsalicylate	','.	','NN	','IN	NN	','NN	','SENT	','tetracycline	','of	absorption	','bismuth_subsalicylate	','.	','is	impaired	','','','VBZ	VVN	','','','be	impair	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS)))), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Absorption, (NNP^NP Absorption), (NP^NP-B (NNP^NP Absorption)), (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameS)), (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))), (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS)))), (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))))), (S^ROOT-v (NP^S-R (NP^NP-B (NNP^NP Absorption)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (VBZ^VP-BE is) (VP-VBN-v (VBN^VP impaired) (PP^VP (IN^PP by) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameS.^S. S^ROOT-vNP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameS.^S. NP^S-RNP^NP-BNNP^NPAbsorptionPP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BNNP^NPAbsorption NNP^NPAbsorption Absorption PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vVBZ^VP-BEisVP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameS VBZ^VP-BEis is VP-VBN-vVBN^VPimpairedPP^VPIN^PPbyNP^PP-BNNP^NPDrugNameS VBN^VPimpaired impaired PP^VPIN^PPbyNP^PP-BNNP^NPDrugNameS IN^PPby by NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s4|DDI-DrugBank.d500.s4.e0|DDI-DrugBank.d500.s4.e1','','Barbiturates',' #','carbamazepine','me #  and phenytoin decrease the half-life of doxycycline.','null','null','null','[]','[me, #, and, phenytoin]','','','','NNSBarbiturates ,, ','NNSbarbiturate ,, ','NNSbarbit ,, ','NNcarbamazepine ,, CCand NNphenytoin VVPdecrease DTthe NNhalf-life INof NNdoxycycline SENT. ','NNcarbamazepine ,, CCand NNphenytoin VVPdecrease DTthe NNhalf-life INof NNdoxycycline SENT. ','NNcarbamazepin ,, CCand NNphenytoin VVPdecreas DTthe NNhalfl INof NNdoxycyclin SENT. ','barbit , carbamazepin , and phenytoin decreas the halfl of doxycyclin . ','Barbiturates	','','carbamazepine	',',	and	phenytoin	','NNS	','','NN	',',	CC	NN	','barbiturate	','','carbamazepine	',',	and	phenytoin	','','','decrease	','','','VVP	','','','decrease	','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP DrugNameS) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)), (NNP^NP DrugNameS), DrugNameS]','[DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP DrugNameS) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)), (S^ROOT-v (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP DrugNameS) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP doxycycline))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-BNNP^NPDrugNameF,^NP,NNP^NPDrugNameS,^NP,CC^NP-CandNNP^NPphenytoinVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline.^S. S^ROOT-vNP^S-BNNP^NPDrugNameF,^NP,NNP^NPDrugNameS,^NP,CC^NP-CandNNP^NPphenytoinVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline.^S. NP^S-BNNP^NPDrugNameF,^NP,NNP^NPDrugNameS,^NP,CC^NP-CandNNP^NPphenytoin NNP^NPDrugNameF DrugNameF ,^NP, , NNP^NPDrugNameS DrugNameS ,^NP, , CC^NP-Cand and NNP^NPphenytoin phenytoin VP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline VB^VPdecrease decrease NP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline NP^NP-BDT^NPtheNN^NPhalf-life DT^NPthe the NN^NPhalf-life half-life PP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline IN^PP-Nof of NP^PP-BNN^NPdoxycycline NN^NPdoxycycline doxycycline .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s4|DDI-DrugBank.d500.s4.e0|DDI-DrugBank.d500.s4.e2','','Barbiturates',' #  carbamazepine #  ','phenytoin','Name decrease the half-life of doxycycline.','null','null','null','[]','[Name, decrease, the, half-life]','','','','NNSBarbiturates ,, NNcarbamazepine ,, CCand ','NNSbarbiturate ,, NNcarbamazepine ,, CCand ','NNSbarbit ,, NNcarbamazepin ,, CCand ','NNphenytoin VVPdecrease DTthe NNhalf-life INof NNdoxycycline SENT. ','NNphenytoin VVPdecrease DTthe NNhalf-life INof NNdoxycycline SENT. ','NNphenytoin VVPdecreas DTthe NNhalfl INof NNdoxycyclin SENT. ','barbit , carbamazepin , and phenytoin decreas the halfl of doxycyclin . ','Barbiturates	','','phenytoin	','decrease	the	half-life	','NNS	','','NN	','VVP	DT	NN	','barbiturate	','','phenytoin	','decrease	the	half-life	','','','decrease	','','','VVP	','','','decrease	','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)), (S^ROOT-v (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP doxycycline))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-BNNP^NPDrugNameF,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPDrugNameSVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline.^S. S^ROOT-vNP^S-BNNP^NPDrugNameF,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPDrugNameSVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline.^S. NP^S-BNNP^NPDrugNameF,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPDrugNameS NNP^NPDrugNameF DrugNameF ,^NP, , NNP^NPcarbamazepine carbamazepine ,^NP, , CC^NP-Cand and NNP^NPDrugNameS DrugNameS VP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline VB^VPdecrease decrease NP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline NP^NP-BDT^NPtheNN^NPhalf-life DT^NPthe the NN^NPhalf-life half-life PP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline IN^PP-Nof of NP^PP-BNN^NPdoxycycline NN^NPdoxycycline doxycycline .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s4|DDI-DrugBank.d500.s4.e0|DDI-DrugBank.d500.s4.e3','','Barbiturates',' #  carbamazepine #  and phenytoin decrease the half-life','doxycycline','Name.','null','null','null','[]','[Name, null]','','','','NNSBarbiturates ,, NNcarbamazepine ,, CCand NNphenytoin VVPdecrease DTthe NNhalf-life INof ','NNSbarbiturate ,, NNcarbamazepine ,, CCand NNphenytoin VVPdecrease DTthe NNhalf-life INof ','NNSbarbit ,, NNcarbamazepin ,, CCand NNphenytoin VVPdecreas DTthe NNhalfl INof ','NNdoxycycline SENT. ','NNdoxycycline SENT. ','NNdoxycyclin SENT. ','barbit , carbamazepin , and phenytoin decreas the halfl of doxycyclin . ','Barbiturates	','','doxycycline	','.	','NNS	','','NN	','SENT	','barbiturate	','','doxycycline	','.	','decrease	','','','VVP	','','','decrease	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)), (S^ROOT-v (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))), (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameS)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))), (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS)))), (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))), (S^ROOT-v (NP^S-B (NNP^NP DrugNameF) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-BNNP^NPDrugNameF,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPphenytoinVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS.^S. S^ROOT-vNP^S-BNNP^NPDrugNameF,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPphenytoinVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS.^S. NP^S-BNNP^NPDrugNameF,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPphenytoin NNP^NPDrugNameF DrugNameF ,^NP, , NNP^NPcarbamazepine carbamazepine ,^NP, , CC^NP-Cand and NNP^NPphenytoin phenytoin VP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS VB^VPdecrease decrease NP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS NP^NP-BDT^NPtheNN^NPhalf-life DT^NPthe the NN^NPhalf-life half-life PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS IN^PP-Nof of NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s4|DDI-DrugBank.d500.s4.e1|DDI-DrugBank.d500.s4.e2','Barbiturates #','carbamazepine','me #  ','phenytoin','Name decrease the half-life of doxycycline.','null','null','null','[Barbiturates, #]','[Name, decrease, the, half-life]','NNSBarbiturates ,, ','NNSbarbiturate ,, ','NNSbarbit ,, ','NNcarbamazepine ,, CCand ','NNcarbamazepine ,, CCand ','NNcarbamazepin ,, CCand ','NNphenytoin VVPdecrease DTthe NNhalf-life INof NNdoxycycline SENT. ','NNphenytoin VVPdecrease DTthe NNhalf-life INof NNdoxycycline SENT. ','NNphenytoin VVPdecreas DTthe NNhalfl INof NNdoxycyclin SENT. ','barbit , carbamazepin , and phenytoin decreas the halfl of doxycyclin . ','carbamazepine	',',	Barbiturates	','phenytoin	','decrease	the	half-life	','NN	',',	NNS	','NN	','VVP	DT	NN	','carbamazepine	',',	barbiturate	','phenytoin	','decrease	the	half-life	','','','decrease	','','','VVP	','','','decrease	','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Barbiturates, (NNP^NP Barbiturates), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)), (S^ROOT-v (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameS)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP doxycycline))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-BNNP^NPBarbiturates,^NP,NNP^NPDrugNameF,^NP,CC^NP-CandNNP^NPDrugNameSVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline.^S. S^ROOT-vNP^S-BNNP^NPBarbiturates,^NP,NNP^NPDrugNameF,^NP,CC^NP-CandNNP^NPDrugNameSVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline.^S. NP^S-BNNP^NPBarbiturates,^NP,NNP^NPDrugNameF,^NP,CC^NP-CandNNP^NPDrugNameS NNP^NPBarbiturates Barbiturates ,^NP, , NNP^NPDrugNameF DrugNameF ,^NP, , CC^NP-Cand and NNP^NPDrugNameS DrugNameS VP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline VB^VPdecrease decrease NP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline NP^NP-BDT^NPtheNN^NPhalf-life DT^NPthe the NN^NPhalf-life half-life PP^NPIN^PP-NofNP^PP-BNN^NPdoxycycline IN^PP-Nof of NP^PP-BNN^NPdoxycycline NN^NPdoxycycline doxycycline .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s4|DDI-DrugBank.d500.s4.e1|DDI-DrugBank.d500.s4.e3','Barbiturates #','carbamazepine','me #  and phenytoin decrease the half-life','doxycycline','Name.','null','null','null','[Barbiturates, #]','[Name, null]','NNSBarbiturates ,, ','NNSbarbiturate ,, ','NNSbarbit ,, ','NNcarbamazepine ,, CCand NNphenytoin VVPdecrease DTthe NNhalf-life INof ','NNcarbamazepine ,, CCand NNphenytoin VVPdecrease DTthe NNhalf-life INof ','NNcarbamazepin ,, CCand NNphenytoin VVPdecreas DTthe NNhalfl INof ','NNdoxycycline SENT. ','NNdoxycycline SENT. ','NNdoxycyclin SENT. ','barbit , carbamazepin , and phenytoin decreas the halfl of doxycyclin . ','carbamazepine	',',	Barbiturates	','doxycycline	','.	','NN	',',	NNS	','NN	','SENT	','carbamazepine	',',	barbiturate	','doxycycline	','.	','decrease	','','','VVP	','','','decrease	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)), (S^ROOT-v (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))), (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Barbiturates, (NNP^NP Barbiturates), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameS)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))), (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS)))), (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))), (S^ROOT-v (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP DrugNameF) (,^NP ,) (CC^NP-C and) (NNP^NP phenytoin)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-BNNP^NPBarbiturates,^NP,NNP^NPDrugNameF,^NP,CC^NP-CandNNP^NPphenytoinVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS.^S. S^ROOT-vNP^S-BNNP^NPBarbiturates,^NP,NNP^NPDrugNameF,^NP,CC^NP-CandNNP^NPphenytoinVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS.^S. NP^S-BNNP^NPBarbiturates,^NP,NNP^NPDrugNameF,^NP,CC^NP-CandNNP^NPphenytoin NNP^NPBarbiturates Barbiturates ,^NP, , NNP^NPDrugNameF DrugNameF ,^NP, , CC^NP-Cand and NNP^NPphenytoin phenytoin VP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS VB^VPdecrease decrease NP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS NP^NP-BDT^NPtheNN^NPhalf-life DT^NPthe the NN^NPhalf-life half-life PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS IN^PP-Nof of NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS .^S. .','Doxycycline_ddi.xml'
1,3,'DDI-DrugBank.d500.s4|DDI-DrugBank.d500.s4.e2|DDI-DrugBank.d500.s4.e3','Barbiturates #  carbamazepine #  ','phenytoin','Name decrease the half-life','doxycycline','Name.','null','null','null','[#, carbamazepine, #]','[Name, null]','NNSBarbiturates ,, NNcarbamazepine ,, CCand ','NNSbarbiturate ,, NNcarbamazepine ,, CCand ','NNSbarbit ,, NNcarbamazepin ,, CCand ','NNphenytoin VVPdecrease DTthe NNhalf-life INof ','NNphenytoin VVPdecrease DTthe NNhalf-life INof ','NNphenytoin VVPdecreas DTthe NNhalfl INof ','NNdoxycycline SENT. ','NNdoxycycline SENT. ','NNdoxycyclin SENT. ','barbit , carbamazepin , and phenytoin decreas the halfl of doxycyclin . ','phenytoin	','and	,	carbamazepine	','doxycycline	','.	','NN	','CC	,	NN	','NN	','SENT	','phenytoin	','and	,	carbamazepine	','doxycycline	','.	','decrease	','','','VVP	','','','decrease	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameF)), (S^ROOT-v (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameF)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))), (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[Barbiturates, (NNP^NP Barbiturates), (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameS)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))), (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS)))), (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))), (S^ROOT-v (NP^S-B (NNP^NP Barbiturates) (,^NP ,) (NNP^NP carbamazepine) (,^NP ,) (CC^NP-C and) (NNP^NP DrugNameF)) (VP^S-VB-v (VB^VP decrease) (NP^VP-R (NP^NP-B (DT^NP the) (NN^NP half-life)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameS))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-BNNP^NPBarbiturates,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPDrugNameFVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS.^S. S^ROOT-vNP^S-BNNP^NPBarbiturates,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPDrugNameFVP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS.^S. NP^S-BNNP^NPBarbiturates,^NP,NNP^NPcarbamazepine,^NP,CC^NP-CandNNP^NPDrugNameF NNP^NPBarbiturates Barbiturates ,^NP, , NNP^NPcarbamazepine carbamazepine ,^NP, , CC^NP-Cand and NNP^NPDrugNameF DrugNameF VP^S-VB-vVB^VPdecreaseNP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS VB^VPdecrease decrease NP^VP-RNP^NP-BDT^NPtheNN^NPhalf-lifePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS NP^NP-BDT^NPtheNN^NPhalf-life DT^NPthe the NN^NPhalf-life half-life PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameS IN^PP-Nof of NP^PP-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS .^S. .','Doxycycline_ddi.xml'
1,2,'DDI-DrugBank.d500.s5|DDI-DrugBank.d500.s5.e0|DDI-DrugBank.d500.s5.e1','The concurrent use of ','tetracycline',' and ','Penthrane',' (methoxyflurane) has been reported to result in fatal renal toxicity.','null','null','null','[concurrent, use, of]','[, methoxyflurane, has, been]','DTThe JJconcurrent NNuse INof ','DTthe JJconcurrent NNuse INof ','DTThe JJconcur NNuse INof ','NNtetracycline CCand ','NNtetracycline CCand ','NNtetracyclin CCand ','NPPenthrane NN-LRB- NNmethoxyflurane NN-RRB- VHZhas VBNbeen VVNreported TOto VVresult INin JJfatal JJrenal NNtoxicity SENT. ','NPPenthrane NN-LRB- NNmethoxyflurane NN-RRB- VHZhave VBNbe VVNreport TOto VVresult INin JJfatal JJrenal NNtoxicity SENT. ','NPpenthr NNlrb NNmethoxyfl NNrrb VHZhas VBNbeen VVNreport TOto VVresult INin JJfat JJren NNtox SENT. ','The concur use of tetracyclin and penthr lrb methoxyfl rrb has been report to result in fat ren tox . ','tetracycline	','of	use	concurrent	','Penthrane	','-LRB-	methoxyflurane	-RRB-	','NN	','IN	NN	JJ	','NP	','NN	NN	NN	','tetracycline	','of	use	concurrent	','Penthrane	','-LRB-	methoxyflurane	-RRB-	','','','has	','','','VHZ	','','','have	','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[The, (DT^NP The), (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)), (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS))), (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS))), (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)))), (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NN^NP methoxyflurane)) (-RRB-^PRN -RRB-))), (S^ROOT-v (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP DrugNameS)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NN^NP methoxyflurane)) (-RRB-^PRN -RRB-))) (VP^S-VBF-v (VBZ^VP-HV has) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP reported) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP result) (PP^VP (IN^PP in) (NP^PP-B (JJ^NP fatal) (JJ^NP renal) (NN^NP toxicity))))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPDrugNameSPRN^NP-LRB-^PRN-LRB-NP^PRN-BNN^NPmethoxyflurane-RRB-^PRN-RRB-VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity.^S. S^ROOT-vNP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPDrugNameSPRN^NP-LRB-^PRN-LRB-NP^PRN-BNN^NPmethoxyflurane-RRB-^PRN-RRB-VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity.^S. NP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPDrugNameSPRN^NP-LRB-^PRN-LRB-NP^PRN-BNN^NPmethoxyflurane-RRB-^PRN-RRB- NP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPDrugNameS NP^NP-BDT^NPTheJJ^NPconcurrentNN^NPuse DT^NPThe The JJ^NPconcurrent concurrent NN^NPuse use PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPDrugNameS IN^PP-Nof of NP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPDrugNameS NNP^NPDrugNameF DrugNameF CC^NP-Cand and NNP^NPDrugNameS DrugNameS PRN^NP-LRB-^PRN-LRB-NP^PRN-BNN^NPmethoxyflurane-RRB-^PRN-RRB- -LRB-^PRN-LRB- -LRB- NP^PRN-BNN^NPmethoxyflurane NN^NPmethoxyflurane methoxyflurane -RRB-^PRN-RRB- -RRB- VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBZ^VP-HVhas has VP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBN^VP-BEbeen been VP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBN^VPreported reported S^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity TO^VPto to VP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VB^VPresult result PP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity IN^PPin in NP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity JJ^NPfatal fatal JJ^NPrenal renal NN^NPtoxicity toxicity .^S. .','Doxycycline_ddi.xml'
1,2,'DDI-DrugBank.d500.s5|DDI-DrugBank.d500.s5.e0|DDI-DrugBank.d500.s5.e2','The concurrent use of ','tetracycline',' and Penthrane (','methoxyflurane',') has been reported to result in fatal renal toxicity.','null','null','null','[concurrent, use, of]','[, has, been, reported]','DTThe JJconcurrent NNuse INof ','DTthe JJconcurrent NNuse INof ','DTThe JJconcur NNuse INof ','NNtetracycline CCand NPPenthrane NN-LRB- ','NNtetracycline CCand NPPenthrane NN-LRB- ','NNtetracyclin CCand NPpenthr NNlrb ','NNmethoxyflurane NN-RRB- VHZhas VBNbeen VVNreported TOto VVresult INin JJfatal JJrenal NNtoxicity SENT. ','NNmethoxyflurane NN-RRB- VHZhave VBNbe VVNreport TOto VVresult INin JJfatal JJrenal NNtoxicity SENT. ','NNmethoxyfl NNrrb VHZhas VBNbeen VVNreport TOto VVresult INin JJfat JJren NNtox SENT. ','The concur use of tetracyclin and penthr lrb methoxyfl rrb has been report to result in fat ren tox . ','tetracycline	','of	use	concurrent	','methoxyflurane	','-RRB-	has	been	','NN	','IN	NN	JJ	','NN	','NN	VHZ	VBN	','tetracycline	','of	use	concurrent	','methoxyflurane	','-RRB-	have	be	','','','has	','','','VHZ	','','','have	','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane))), (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)))), (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-))), (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-)), (NP^PRN-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[The, (DT^NP The), (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)), (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane))), (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PRN-B (NNP^NP DrugNameS)), (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-)), (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-))), (S^ROOT-v (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF) (CC^NP-C and) (NNP^NP Penthrane)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-))) (VP^S-VBF-v (VBZ^VP-HV has) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP reported) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP result) (PP^VP (IN^PP in) (NP^PP-B (JJ^NP fatal) (JJ^NP renal) (NN^NP toxicity))))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPPenthranePRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB-VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity.^S. S^ROOT-vNP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPPenthranePRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB-VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity.^S. NP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPPenthranePRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB- NP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPPenthrane NP^NP-BDT^NPTheJJ^NPconcurrentNN^NPuse DT^NPThe The JJ^NPconcurrent concurrent NN^NPuse use PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPPenthrane IN^PP-Nof of NP^PP-BNNP^NPDrugNameFCC^NP-CandNNP^NPPenthrane NNP^NPDrugNameF DrugNameF CC^NP-Cand and NNP^NPPenthrane Penthrane PRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB- -LRB-^PRN-LRB- -LRB- NP^PRN-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS -RRB-^PRN-RRB- -RRB- VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBZ^VP-HVhas has VP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBN^VP-BEbeen been VP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBN^VPreported reported S^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity TO^VPto to VP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VB^VPresult result PP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity IN^PPin in NP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity JJ^NPfatal fatal JJ^NPrenal renal NN^NPtoxicity toxicity .^S. .','Doxycycline_ddi.xml'
0,0,'DDI-DrugBank.d500.s5|DDI-DrugBank.d500.s5.e1|DDI-DrugBank.d500.s5.e2','The concurrent use of tetracycline and ','Penthrane',' (','methoxyflurane',') has been reported to result in fatal renal toxicity.','null','null','null','[of, tetracycline, and]','[, has, been, reported]','DTThe JJconcurrent NNuse INof NNtetracycline CCand ','DTthe JJconcurrent NNuse INof NNtetracycline CCand ','DTThe JJconcur NNuse INof NNtetracyclin CCand ','NPPenthrane NN-LRB- ','NPPenthrane NN-LRB- ','NPpenthr NNlrb ','NNmethoxyflurane NN-RRB- VHZhas VBNbeen VVNreported TOto VVresult INin JJfatal JJrenal NNtoxicity SENT. ','NNmethoxyflurane NN-RRB- VHZhave VBNbe VVNreport TOto VVresult INin JJfatal JJrenal NNtoxicity SENT. ','NNmethoxyfl NNrrb VHZhas VBNbeen VVNreport TOto VVresult INin JJfat JJren NNtox SENT. ','The concur use of tetracyclin and penthr lrb methoxyfl rrb has been report to result in fat ren tox . ','Penthrane	','and	tetracycline	of	','methoxyflurane	','-RRB-	has	been	','NP	','CC	NN	IN	','NN	','NN	VHZ	VBN	','Penthrane	','and	tetracycline	of	','methoxyflurane	','-RRB-	have	be	','','','has	','','','VHZ	','','','have	','[DrugNameF, (NN^NP DrugNameF), (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF))), (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)))), (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-))), (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-)), (NP^PRN-B (NNP^NP DrugNameS)), (NNP^NP DrugNameS), DrugNameS]','[The, (DT^NP The), (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)), (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF))), (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)), (NN^NP DrugNameF), DrugNameF]','[DrugNameS, (NNP^NP DrugNameS), (NP^PRN-B (NNP^NP DrugNameS)), (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-)), (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-))), (S^ROOT-v (NP^S (NP^NP-R (NP^NP-B (DT^NP The) (JJ^NP concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NN^NP tetracycline) (CC^NP-C and) (NN^NP DrugNameF)))) (PRN^NP (-LRB-^PRN -LRB-) (NP^PRN-B (NNP^NP DrugNameS)) (-RRB-^PRN -RRB-))) (VP^S-VBF-v (VBZ^VP-HV has) (VP-VBN-v (VBN^VP-BE been) (VP-VBN-v (VBN^VP reported) (S^VP-U-v-G (VP^S-TO-v (TO^VP to) (VP-VB-v (VB^VP result) (PP^VP (IN^PP in) (NP^PP-B (JJ^NP fatal) (JJ^NP renal) (NN^NP toxicity))))))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNN^NPtetracyclineCC^NP-CandNN^NPDrugNameFPRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB-VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity.^S. S^ROOT-vNP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNN^NPtetracyclineCC^NP-CandNN^NPDrugNameFPRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB-VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity.^S. NP^SNP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNN^NPtetracyclineCC^NP-CandNN^NPDrugNameFPRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB- NP^NP-RNP^NP-BDT^NPTheJJ^NPconcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNN^NPtetracyclineCC^NP-CandNN^NPDrugNameF NP^NP-BDT^NPTheJJ^NPconcurrentNN^NPuse DT^NPThe The JJ^NPconcurrent concurrent NN^NPuse use PP^NPIN^PP-NofNP^PP-BNN^NPtetracyclineCC^NP-CandNN^NPDrugNameF IN^PP-Nof of NP^PP-BNN^NPtetracyclineCC^NP-CandNN^NPDrugNameF NN^NPtetracycline tetracycline CC^NP-Cand and NN^NPDrugNameF DrugNameF PRN^NP-LRB-^PRN-LRB-NP^PRN-BNNP^NPDrugNameS-RRB-^PRN-RRB- -LRB-^PRN-LRB- -LRB- NP^PRN-BNNP^NPDrugNameS NNP^NPDrugNameS DrugNameS -RRB-^PRN-RRB- -RRB- VP^S-VBF-vVBZ^VP-HVhasVP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBZ^VP-HVhas has VP-VBN-vVBN^VP-BEbeenVP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBN^VP-BEbeen been VP-VBN-vVBN^VPreportedS^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VBN^VPreported reported S^VP-U-v-GVP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VP^S-TO-vTO^VPtoVP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity TO^VPto to VP-VB-vVB^VPresultPP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity VB^VPresult result PP^VPIN^PPinNP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity IN^PPin in NP^PP-BJJ^NPfatalJJ^NPrenalNN^NPtoxicity JJ^NPfatal fatal JJ^NPrenal renal NN^NPtoxicity toxicity .^S. .','Doxycycline_ddi.xml'
1,2,'DDI-DrugBank.d500.s6|DDI-DrugBank.d500.s6.e0|DDI-DrugBank.d500.s6.e1','Concurrent use of ','tetracycline',' may render oral ','contraceptives',' less effective.','null','null','null','[Concurrent, use, of]','[, less, effective, null]','JJConcurrent NNuse INof ','JJconcurrent NNuse INof ','JJconcur NNuse INof ','NNtetracycline MDmay VVrender JJoral ','NNtetracycline MDmay VVrender JJoral ','NNtetracyclin MDmay VVrend JJor ','NNScontraceptives RBRless JJeffective SENT. ','NNScontraceptive RBRless JJeffective SENT. ','NNScontraceiv RBRless JJeffect SENT. ','concur use of tetracyclin may rend or contraceiv less effect . ','tetracycline	','of	use	Concurrent	','contraceptives	','less	effective	.	','NN	','IN	NN	JJ	','NNS	','RBR	JJ	SENT	','tetracycline	','of	use	concurrent	','contraceptive	','less	effective	.	','render	','','','VV	','','','render	','','','[DrugNameF, (NNP^NP DrugNameF), (NP^PP-B (NNP^NP DrugNameF)), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^S-R (NP^NP-B (JJ^NP Concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (S^ROOT-v (NP^S-R (NP^NP-B (JJ^NP Concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP render) (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective))))) (.^S .)), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP render) (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective))))), (VP-VB-v (VB^VP render) (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective)))), (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective))), (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)), (NNS^NP DrugNameS), DrugNameS]','[Concurrent, (JJ^NP Concurrent), (NP^NP-B (JJ^NP Concurrent) (NN^NP use)), (NP^S-R (NP^NP-B (JJ^NP Concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))), (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF))), (NP^PP-B (NNP^NP DrugNameF)), (NNP^NP DrugNameF), DrugNameF]','[DrugNameS, (NNS^NP DrugNameS), (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)), (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective))), (VP-VB-v (VB^VP render) (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective)))), (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP render) (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective))))), (S^ROOT-v (NP^S-R (NP^NP-B (JJ^NP Concurrent) (NN^NP use)) (PP^NP (IN^PP-N of) (NP^PP-B (NNP^NP DrugNameF)))) (VP^S-VBF-v (MD^VP may) (VP-VB-v (VB^VP render) (S^VP (NP^S-B (JJ^NP oral) (NNS^NP DrugNameS)) (ADJP^S (RBR^ADJP less) (JJ^ADJP effective))))) (.^S .)), (.^S .), .]',' ROOTS^ROOT-vNP^S-RNP^NP-BJJ^NPConcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vMD^VPmayVP-VB-vVB^VPrenderS^VPNP^S-BJJ^NPoralNNS^NPDrugNameSADJP^SRBR^ADJPlessJJ^ADJPeffective.^S. S^ROOT-vNP^S-RNP^NP-BJJ^NPConcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameFVP^S-VBF-vMD^VPmayVP-VB-vVB^VPrenderS^VPNP^S-BJJ^NPoralNNS^NPDrugNameSADJP^SRBR^ADJPlessJJ^ADJPeffective.^S. NP^S-RNP^NP-BJJ^NPConcurrentNN^NPusePP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF NP^NP-BJJ^NPConcurrentNN^NPuse JJ^NPConcurrent Concurrent NN^NPuse use PP^NPIN^PP-NofNP^PP-BNNP^NPDrugNameF IN^PP-Nof of NP^PP-BNNP^NPDrugNameF NNP^NPDrugNameF DrugNameF VP^S-VBF-vMD^VPmayVP-VB-vVB^VPrenderS^VPNP^S-BJJ^NPoralNNS^NPDrugNameSADJP^SRBR^ADJPlessJJ^ADJPeffective MD^VPmay may VP-VB-vVB^VPrenderS^VPNP^S-BJJ^NPoralNNS^NPDrugNameSADJP^SRBR^ADJPlessJJ^ADJPeffective VB^VPrender render S^VPNP^S-BJJ^NPoralNNS^NPDrugNameSADJP^SRBR^ADJPlessJJ^ADJPeffective NP^S-BJJ^NPoralNNS^NPDrugNameS JJ^NPoral oral NNS^NPDrugNameS DrugNameS ADJP^SRBR^ADJPlessJJ^ADJPeffective RBR^ADJPless less JJ^ADJPeffective effective .^S. .','Doxycycline_ddi.xml'
